Substance / Medication

Naloxone hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Effect of naloxone hydrochloride on osteogenesis in chick embryos.
Liskov A V, Solnyshkova T G, Frolov B A et al. · Bull Exp Biol Med · 2005
PMID: 16027845Observational
Transdermal delivery of naloxone hydrochloride using minimally invasive physical ablation techniques.
Tijani Akeemat O, Dandekar Amruta A, Karve Tanvi et al. · Int J Pharm · 2023
PMID: 37336303Other
Compatibility and stability of morphine sulphate and naloxone hydrochloride in 0.9% sodium chloride for injection.
Kistner Charlotte, Ensom Mary H H, Decarie Diane et al. · Can J Hosp Pharm · 2013
PMID: 23814283OtherFull text (PMC)
Microneedle-mediated transdermal delivery of naloxone hydrochloride for treatment of opioid overdose.
Puri Ashana, Frempong Dorcas, Mishra Dhruv et al. · Int J Pharm · 2021
PMID: 34048932Preclinical
Study of the Acute Toxicity of a New Dosage Form of Naloxone Hydrochloride for Intranasal Administration.
Bariev Eduard A, Krasnyuk Ivan I, Anurova Maria N et al. · Drug Res (Stuttg) · 2020
PMID: 31525817Preclinical
Pharmacokinetics and pharmacodynamics of intranasal and intravenous naloxone hydrochloride administration in healthy dogs.
Wahler Brandon M, Lerche Phillip, Ricco Pereira Carolina H et al. · Am J Vet Res · 2019
PMID: 31246123Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Naloxone hydrochloride (substance)
SNOMED CT
21518006
UMLS CUI
C0700549

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.